The use of mechanical circulatory support for patients presenting with cardiogenic shock is
rapidly increasing. Currently, there is only limited and conflicting evidence available …

Anticoagulation of patients treated with the Impella percutaneous mechanical circulatory
support (MCS) devices is complex and lacks consistency across centers, potentially …

Introduction Despite advances in heart failure therapies and percutaneous coronary
interventions, survival for cardiogenic shock remains poor. Percutaneous ventricular assist …

Cardiogenic shock (CS) is a complex multifactorial clinical syndrome, developing as a
continuum, and progressing from the initial insult (underlying cause) to the subsequent …

Interest in the use of percutaneous left ventricular assist devices (p-LVADs) for patients
undergoing high-risk percutaneous coronary intervention (PCI) is growing rapidly. The …